A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer
Open Access
- 12 June 2025
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (3) , e13859
Abstract
Background: Cancer cachexia is associated with poor quality of life (QoL) and reduced survival in patients with cancer. The European Organization for Research and Treatment of Cancer (EORTC) QLQ‐C30 is a widely used cancer‐specific health‐related QoL questionnaire that comprises 15 scales, consisting of five multi‐item functional scales, three multi‐item symptom scales, six single‐item symptom scales and a global health and quality‐of‐life scale. Our study aimed to analyse the association of each scale in the EORTC QLQ‐C30 questionnaire with cachexia and explore its influence on survival outcomes in patients with gastric cancer and cachexia.Methods: This multicentre cohort study enrolled 3158 patients with gastric cancer, among whom 1711 were diagnosed with cachexia. Logistic regression analysis was conducted to identify the individual scales of the EORTC QLQ‐C30 questionnaire significantly affected by cachexia. The Cox model was employed to evaluate the prognostic performance of EORTC QLQ‐C30 questionnaire scales in patients with gastric cancer and cachexia.Results: In this study, the median age of patients with gastric cancer was 67.00 (interquartile range [IQR], 58.00–74.00) years, with 2178 (69.0%) men and 980 (31.0%) women. In logistic regression analyses, scales such as physical function (p < 0.001), global quality of life (p = 0.022), fatigue (p < 0.001), nausea and vomiting (p < 0.001), dyspnoea (p = 0.004), insomnia (p = 0.007), loss of appetite (p < 0.001), constipation (p < 0.001), diarrhoea (p = 0.017) and summary score (p = 0.039) were significantly associated with cachexia in patients with gastric cancer. According to the receiver operating characteristics (ROC) curves, loss of appetite was the most significant scale associated with cachexia. Based on multivariate Cox analyses, the scales of physical function (HR = 1.33, 95% CI = 1.00–1.77, p = 0.049), role function (HR = 1.48, 95% CI = 1.15–1.90, p = 0.002), social function (HR = 1.90, 95% CI = 1.40–2.56, p < 0.001), global quality of life (HR = 1.45, 95% CI = 1.05–2.00, p = 0.026), financial impact (HR = 1.53, 95% CI = 1.15–2.03, p = 0.003) and summary score (HR = 1.39, 95% CI = 1.01–1.91, p = 0.042) were independent risk factors for survival in patients with gastric cancer and cachexia. The concordance index (C‐index) and area under the curve (AUC) value for survival prediction were the highest for the social function scale.Conclusion: The QoL of gastric cancer patients with cachexia was significantly reduced. Certain scales in the EORTC QLQ‐C30 were significantly associated with cachexia, especially the loss of appetite scale, and survival outcomes in patients with gastric cancer, especially social function. Emphasizing these scales can heighten our awareness of the impact of cachexia on QoL and enhance our ability to predict the survival of patients with gastric cancer and cachexia.Trial Registration: ChiCTR: 1800020329Keywords
Funding Information
- National Basic Research Program of China (2022YFC2009600)
- National Natural Science Foundation of China (82303908)
This publication has 31 references indexed in Scilit:
- Interconversion of three measures of performance status: An empirical analysisEuropean Journal of Cancer, 2010
- Treatment of Nausea and Vomiting in Terminally Ill Cancer PatientsDrugs, 2008
- Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods studyPalliative Medicine, 2007
- Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosisThe American Journal of Clinical Nutrition, 2006
- Cancer-Related Anorexia/Cachexia Syndrome and Oxidative Stress: An Innovative Approach beyond Current TreatmentCancer Epidemiology, Biomarkers & Prevention, 2004
- Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acidsBritish Journal of Cancer, 2004
- Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patientsBritish Journal of Cancer, 2001
- Cancer: impact of nutrition intervention outcome—nutrition issues for patientsNutrition, 2001
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980